Titel

Merkliste
1 Ergebnisse

Image_2_Study of epirubicin sustained–release chemoablation..:

Liangliang Meng (9500122) ; Zhenjun Wang (1662082) ; Zhonghui Hou (14281247)...
https://figshare.com/articles/figure/Image_2_Study_of_epirubicin_sustained_release_chemoablation_in_tumor_suppression_and_tumor_microenvironment_remodeling_jpeg/21754826. , 2022

Link: https://doi.org/10.3389/fimmu.2022.1064047.s002

RT Journal
T1 <Title>Image_2_Study of epirubicin sustained–release chemoablation in tumor suppression and tumor microenvironment remodeling.jpeg</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftunivfreestate:oai:figshare.com:article_21754826&Exemplar=1&LAN=DE
				
A1 Liangliang Meng (9500122)
A1 Zhenjun Wang (1662082)
A1 Zhonghui Hou (14281247)
A1 Hufei Wang (11166303)
A1 Xiao Zhang (152326)
A1 Xiaobo Zhang (77133)
A1 Xiaofeng He (2618752)
A1 Xin Zhang (35492)
A1 Boyu Qin (9408998)
A1 Jing Li (10611)
A1 Zhongliang Zhang (13187023)
A1 Xiaodong Xue (582390)
A1 Yingtian Wei (9500125)
YR 2022
K1 Immunology
K1 Applied Immunology (incl. Antibody Engineering
K1 Xenotransplantation and T-cell Therapies)
K1 Autoimmunity
K1 Cellular Immunology
K1 Humoural Immunology and Immunochemistry
K1 Immunogenetics (incl. Genetic Immunology)
K1 Innate Immunity
K1 Transplantation Immunology
K1 Tumour Immunology
K1 Immunology not elsewhere classified
K1 Genetic Immunology
K1 Animal Immunology
K1 Veterinary Immunology
K1 chemoablation
K1 percutaneous injection
K1 epirubicin (EPI)
K1 drug sustained release
K1 tumor microenvironment
K1 immunotherapy
K1 immune checkpoint inhibitor (ICI)
JF https://figshare.com/articles/figure/Image_2_Study_of_epirubicin_sustained_release_chemoablation_in_tumor_suppression_and_tumor_microenvironment_remodeling_jpeg/21754826
LK http://dx.doi.org/https://doi.org/10.3389/fimmu.2022.1064047.s002
DO https://doi.org/10.3389/fimmu.2022.1064047.s002
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)